{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T04:28:30Z","timestamp":1766377710940,"version":"3.37.3"},"reference-count":149,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Neurol"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Systemic autoimmune diseases can affect the peripheral and central nervous system. In this review, we outline the common inpatient consultations for patients with neurological symptoms from rheumatoid arthritis, Sjogren's syndrome, systemic lupus erythematosus, sarcoidosis, immunoglobulin G4\u2013related disease, Beh\u00e7et's disease, giant cell arteritis, granulomatosis with polyangiitis, microscopic polyangiitis, eosinophilic granulomatosis, polyarteritis nodosa, and ankylosing spondylitis. We discuss the symptoms, diagnostic strategies, and treatment options.<\/jats:p>","DOI":"10.1055\/s-0041-1733790","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T22:34:42Z","timestamp":1633646082000},"page":"541-553","source":"Crossref","is-referenced-by-count":3,"title":["Acute Neurologic Manifestations of Systemic Immune-Mediated Diseases"],"prefix":"10.1055","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3783-9788","authenticated-orcid":false,"given":"Kristin","family":"Galetta","sequence":"additional","affiliation":[{"name":"Division of Hospital Neurology, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamik","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Division of Hospital Neurology, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"F C Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"09","key":"ref2","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"D Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1552-6569.2008.00299.x","article-title":"Rheumatoid leptomeningitis: magnetic resonance imaging and pathologic findings--a case report","volume":"20","author":"A Cianfoni","year":"2010","journal-title":"J Neuroimaging"},{"issue":"07","key":"ref4","first-page":"337","article-title":"Rheumatoid pachymeningitis","volume":"45","author":"H J Tan","year":"2004","journal-title":"Singapore Med J"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/neup.12238","article-title":"Two cases of rheumatoid meningitis","volume":"36","author":"S Magaki","year":"2016","journal-title":"Neuropathology"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/0003-4819-90-5-786","article-title":"Rheumatoid meningitis: a localized immune process","volume":"90","author":"J A Markenson","year":"1979","journal-title":"Ann Intern Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fneur.2019.00666","article-title":"Use of cerebrospinal fluid biomarkers in diagnosis and monitoring of rheumatoid meningitis","volume":"10","author":"M S Nissen","year":"2019","journal-title":"Front Neurol"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10067-003-0788-0","article-title":"Rheumatoid meningitis: an autopsy report and review of the literature","volume":"22","author":"T Kato","year":"2003","journal-title":"Clin Rheumatol"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1212\/WNL.0000000000003744","article-title":"Pearls & Oy-sters: asymmetric meningeal involvement is a common feature of rheumatoid meningitis","volume":"88","author":"S-J Choi","year":"2017","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2018.12.001","article-title":"Rheumatoid meningitis sine arthritis","volume":"328","author":"C Lee Ching","year":"2019","journal-title":"J Neuroimmunol"},{"issue":"02","key":"ref11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/1941874419859769","article-title":"Rheumatoid meningitis: clinical characteristics, diagnostic evaluation, and treatment","volume":"10","author":"A M Parsons","year":"2020","journal-title":"Neurohospitalist"},{"issue":"163","key":"ref12","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fneur.2019.00163","article-title":"Rheumatoid meningitis presenting with acute parkinsonism and protracted non-convulsive seizures: an unusual case presentation and review of treatment strategies","volume":"10","author":"D Pellerin","year":"2019","journal-title":"Front Neurol"},{"issue":"07","key":"ref13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-017-0667-3","article-title":"Rheumatoid vasculitis: a diminishing yet devastating menace","volume":"19","author":"S Kishore","year":"2017","journal-title":"Curr Rheumatol Rep"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.rdc.2017.06.005","article-title":"Neurologic manifestations of rheumatoid arthritis","volume":"43","author":"K DeQuattro","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"omw071","DOI":"10.1093\/omcr\/omw071","article-title":"Refractory rheumatoid vasculitis","volume":"2016","author":"A Kumar","year":"2016","journal-title":"Oxf Med Case Rep"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00296-007-0428-0","article-title":"Central nervous system involvement as a major manifestation of rheumatoid arthritis","volume":"28","author":"M Zolcinski","year":"2008","journal-title":"Rheumatol Int"},{"issue":"05","key":"ref17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2169\/internalmedicine.3866-19","article-title":"Severe mononeuritis multiplex due to rheumatoid vasculitis in rheumatoid arthritis in sustained clinical remission for decades","volume":"59","author":"M Tanemoto","year":"2020","journal-title":"Intern Med"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jbspin.2012.06.014","article-title":"Isolated rheumatoid arthritis-associated cerebral vasculitis: a diagnostic challenge","volume":"80","author":"D Guadalupe Loya-de la Cerda","year":"2013","journal-title":"Joint Bone Spine"},{"key":"ref19","first-page":"65","volume-title":"Epidemiology of Extra-articular Manifestations in Rheumatoid Arthritis","author":"C Turesson","year":"2004"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0002-9343(84)90654-5","article-title":"Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis","volume":"76","author":"D GI Scott","year":"1984","journal-title":"Am J Med"},{"issue":"06","key":"ref21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.2007.081679","article-title":"Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis","volume":"67","author":"X Pu\u00e9chal","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/acr.20689","article-title":"Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: results from the AutoImmunity and Rituximab Registry","volume":"64","author":"X Pu\u00e9chal","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"19","key":"ref23","doi-asserted-by":"crossref","first-page":"e3632","DOI":"10.1097\/MD.0000000000003632","article-title":"Sj\u00f6gren sensory neuronopathy (Sj\u00f6gren ganglionopathy): long-term outcome and treatment response in a series of 13 cases","volume":"95","author":"P R Pereira","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"05","key":"ref24","first-page":"801","article-title":"Radiological cervical spine involvement in patients with rheumatoid arthritis: a cross sectional study","volume":"32","author":"A K Zikou","year":"2005","journal-title":"J Rheumatol"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajo.2009.09.013","article-title":"A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sj\u00f6gren's Syndrome International Registry","volume":"149","author":"J P Whitcher","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","article-title":"American College of Rheumatology classification criteria for Sj\u00f6gren's syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren's International Collaborative Clinical Alliance cohort","volume":"64","author":"S C Shiboski","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref27","first-page":"255","volume-title":"Clinical Features and Pathophysiological Basis of Sensory Neuronopathies (Ganglionopathies)","author":"T Kuntzer","year":"2004"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e485","DOI":"10.1016\/j.lpm.2012.06.002","article-title":"Central and peripheral neurological complications of primary Sj\u00f6gren's syndrome","volume":"41","author":"A-L Fauchais","year":"2012","journal-title":"Presse Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in Sj\u00f6gren's syndrome-associated neuropathy","volume":"128","author":"K Mori","year":"2005","journal-title":"Brain"},{"issue":"02","key":"ref30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.5114\/reum.2018.75521","article-title":"Neurological manifestations of primary Sj\u00f6gren's syndrome","volume":"56","author":"J Perzy\u0144ska-Mazan","year":"2018","journal-title":"Reumatologia"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7326\/0003-4819-104-3-323","article-title":"Primary Sj\u00f6gren's syndrome with central nervous system disease mimicking multiple sclerosis","volume":"104","author":"E L Alexander","year":"1986","journal-title":"Ann Intern Med"},{"issue":"04","key":"ref32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40674-017-0076-9","article-title":"Neurological complications of Sj\u00f6gren's syndrome: diagnosis and management","volume":"3","author":"S S McCoy","year":"2017","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/acr.20318","article-title":"Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry","volume":"62","author":"B Terrier","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"09","key":"ref34","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.21260","article-title":"Rituximab treatment in patients with primary Sj\u00f6gren's syndrome: an open-label phase II study","volume":"52","author":"J Pijpe","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/jnnp.71.4.488","article-title":"Spinal cord magnetic resonance imaging demonstrates sensory neuronal involvement and clinical severity in neuronopathy associated with Sj\u00f6gren's syndrome","volume":"71","author":"K Mori","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/practneurol-2013-000651","article-title":"The neurology of Sjogren's syndrome and the rheumatology of peripheral neuropathy and myelitis","volume":"14","author":"A L Berkowitz","year":"2014","journal-title":"Pract Neurol"},{"issue":"09","key":"ref37","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/acr.20495","article-title":"Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sj\u00f6gren's syndrome: a national multicentric retrospective study","volume":"63","author":"S Rist","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"04","key":"ref38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000052142","article-title":"Plasmapheresis in the treatment of ataxic sensory neuropathy associated with Sj\u00f6gren's syndrome","volume":"45","author":"W H Chen","year":"2001","journal-title":"Eur Neurol"},{"issue":"09","key":"ref39","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1352458511403958","article-title":"Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders","volume":"17","author":"S Jarius","year":"2011","journal-title":"Mult Scler"},{"issue":"08","key":"ref40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1590\/0004-282X20140097","article-title":"Sj\u00f6gren syndrome and neuromyelitis optica spectrum disorder co-exist in a common autoimmune milieu","volume":"72","author":"D C Carvalho","year":"2014","journal-title":"Arq Neuropsiquiatr"},{"issue":"06","key":"ref41","first-page":"888","article-title":"Primary Sj\u00f6gren's syndrome related optic neuritis","volume":"6","author":"W-Q Tang","year":"2013","journal-title":"Int J Ophthalmol"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1177\/1352458519876031","article-title":"The \u201ccentral vein sign\u201d in patients with diagnostic \u201cred flags\u201d for multiple sclerosis: a prospective multicenter 3T study","volume":"26","author":"P Maggi","year":"2020","journal-title":"Mult Scler"},{"issue":"01","key":"ref43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"S J Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jns.2014.11.020","article-title":"Presence of anti-Ro\/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder","volume":"348","author":"J-H Park","year":"2015","journal-title":"J Neurol Sci"},{"issue":"03","key":"ref45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/08916934.2014.883501","article-title":"A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica","volume":"47","author":"A Iyer","year":"2014","journal-title":"Autoimmunity"},{"issue":"03","key":"ref46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/WCO.0000000000000093","article-title":"Longitudinally extensive transverse myelitis","volume":"27","author":"W O Tobin","year":"2014","journal-title":"Curr Opin Neurol"},{"issue":"04","key":"ref47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.semarthrit.2010.05.005","article-title":"Neuromyelitis optica spectrum disorder as an initial presentation of primary Sj\u00f6gren's syndrome","volume":"40","author":"J M Kahlenberg","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"07","key":"ref48","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.clineuro.2005.05.015","article-title":"Subacute aseptic meningitis as neurological manifestation of primary Sj\u00f6gren's syndrome","volume":"108","author":"R Rossi","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jns.2005.01.014","article-title":"Reversible cortical lesions in primary Sj\u00f6gren's syndrome presenting with meningoencephalitis as an initial manifestation","volume":"232","author":"M Hirohata","year":"2005","journal-title":"J Neurol Sci"},{"issue":"04","key":"ref50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.40591","article-title":"Review: nervous system disease in systemic lupus erythematosus: current status and future directions","volume":"71","author":"J G Hanly","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"ref52","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"G K Bertsias","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"03","key":"ref53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"N Schwartz","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40265-015-0534-3","article-title":"Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives","volume":"76","author":"C Magro-Checa","year":"2016","journal-title":"Drugs"},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.3390\/ijms19113588","article-title":"From systemic inflammation to neuroinflammation: the case of neurolupus","volume":"19","author":"M Bendorius","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"01","key":"ref56","doi-asserted-by":"crossref","first-page":"e0001","DOI":"10.5041\/RMMJ.10276","article-title":"Neuropsychiatric systemic lupus erythematosus involvement: Towards a tailored approach to our patients?","volume":"8","author":"R Faria","year":"2017","journal-title":"Rambam Maimonides Med J"},{"issue":"01","key":"ref57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2010.08.001","article-title":"Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis","volume":"41","author":"A Unterman","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.STR.0000254476.05620.14","article-title":"Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus","volume":"38","author":"J Mikdashi","year":"2007","journal-title":"Stroke"},{"issue":"09","key":"ref59","first-page":"894","article-title":"The necessity of stroke prevention in patients with systemic lupus erythematosus","volume":"17","author":"M Saadatnia","year":"2012","journal-title":"J Res Med Sci"},{"issue":"04","key":"ref60","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/STROKEAHA.115.012052","article-title":"Cerebrovascular disease in rheumatic diseases: a systematic review and meta-analysis","volume":"47","author":"S J Wiseman","year":"2016","journal-title":"Stroke"},{"issue":"09","key":"ref61","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/annrheumdis-2016-210973","article-title":"Stroke in systemic lupus erythematosus: a Swedish population-based cohort study","volume":"76","author":"E V Arkema","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ensci.2018.11.001","article-title":"Ischemic stroke as initial manifestation of systemic lupus erythematosus: a case report and review of the literature","volume":"13","author":"S Ioannidis","year":"2018","journal-title":"eNeurologicalSci"},{"issue":"04","key":"ref63","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/acr.22173","article-title":"Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies","volume":"66","author":"M Yurkovich","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"04","key":"ref64","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2362.2010.02263.x","article-title":"Neurological manifestations of antiphospholipid syndrome","volume":"40","author":"C EM Rodrigues","year":"2010","journal-title":"Eur J Clin Invest"},{"issue":"04","key":"ref65","first-page":"780","article-title":"Long term beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy","volume":"28","author":"E F Borba","year":"2001","journal-title":"J Rheumatol"},{"issue":"02","key":"ref66","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/0961203310395803","article-title":"Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies","volume":"20","author":"G Ruiz-Irastorza","year":"2011","journal-title":"Lupus"},{"issue":"12","key":"ref67","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"M A Crowther","year":"2003","journal-title":"N Engl J Med"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1538-7836.2005.01340.x","article-title":"A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)","volume":"3","author":"G Finazzi","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"10","key":"ref69","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.WNL.0000144178.32208.4F","article-title":"Epileptic seizures in systemic lupus erythematosus","volume":"63","author":"S Appenzeller","year":"2004","journal-title":"Neurology"},{"issue":"03","key":"ref70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0961203307086639","article-title":"Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort","volume":"17","author":"R Ramsey-Goldman","year":"2008","journal-title":"Lupus"},{"issue":"03","key":"ref71","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3899\/jrheum.150135","article-title":"Predictors of incident seizure in systemic lupus erythematosus","volume":"43","author":"X Huang","year":"2016","journal-title":"J Rheumatol"},{"issue":"06","key":"ref72","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ard.2007.077594","article-title":"Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)","volume":"67","author":"R M Andrade","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"02","key":"ref73","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/ene.14077","article-title":"Epilepsy in systemic lupus erythematosus: prevalence and risk factors","volume":"27","author":"L Hopia","year":"2020","journal-title":"Eur J Neurol"},{"issue":"05","key":"ref74","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jamaneurol.2014.188","article-title":"Population-level evidence for an autoimmune etiology of epilepsy","volume":"71","author":"M-S Ong","year":"2014","journal-title":"JAMA Neurol"},{"issue":"04","key":"ref75","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1365-2125.2010.03733.x","article-title":"Do selected drugs increase the risk of lupus? A matched case-control study","volume":"70","author":"W M Schoonen","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"09","key":"ref76","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archneur.1985.04060080095022","article-title":"Sarcoidosis and its neurological manifestations","volume":"42","author":"B J Stern","year":"1985","journal-title":"Arch Neurol"},{"issue":"01","key":"ref77","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12883-016-0741-x","article-title":"Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis","volume":"16","author":"D Fritz","year":"2016","journal-title":"BMC Neurol"},{"issue":"04","key":"ref78","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-0037-1604165","article-title":"Neurosarcoidosis","volume":"38","author":"D A Culver","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"issue":"02","key":"ref79","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/qjmed\/92.2.103","article-title":"Central nervous system sarcoidosis--diagnosis and management","volume":"92","author":"J P Zajicek","year":"1999","journal-title":"QJM"},{"issue":"12","key":"ref80","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jamaneurol.2018.2295","article-title":"Definition and consensus diagnostic criteria for neurosarcoidosis: from the neurosarcoidosis consortium consensus group","volume":"75","author":"B J Stern","year":"2018","journal-title":"JAMA Neurol"},{"issue":"02","key":"ref81","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/1941874413519447","article-title":"Neurosarcoidosis: clinical review of a disorder with challenging inpatient presentations and diagnostic considerations","volume":"4","author":"J C Hoyle","year":"2014","journal-title":"Neurohospitalist"},{"issue":"07","key":"ref82","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.3174\/ajnr.A5492","article-title":"Cerebrovascular manifestations of neurosarcoidosis: an underrecognized aspect of the imaging spectrum","volume":"39","author":"G Bathla","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"issue":"14","key":"ref83","doi-asserted-by":"crossref","first-page":"e3277","DOI":"10.1097\/MD.0000000000003277","article-title":"Neurosarcoidosis in a tertiary referral center: a cross-sectional cohort study","volume":"95","author":"S E Leonhard","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"16","key":"ref84","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/archinte.1997.00440370104011","article-title":"Diagnosis and management of neurological sarcoidosis","volume":"157","author":"E E Lower","year":"1997","journal-title":"Arch Intern Med"},{"key":"ref85","first-page":"3642735","article-title":"Two cases of Heerfordt's syndrome: a rare manifestation of sarcoidosis","volume":"2016","author":"K Fujiwara","year":"2016","journal-title":"Case Rep Otolaryngol"},{"issue":"04","key":"ref86","first-page":"655","article-title":"MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment","volume":"20","author":"G A Christoforidis","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"issue":"05","key":"ref87","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1212\/NXI.0000000000000270","article-title":"Optic neuropathy associated with systemic sarcoidosis","volume":"3","author":"D P Kidd","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"01","key":"ref88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: a comprehensive review","volume":"49","author":"M A Judson","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"05","key":"ref89","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3174\/ajnr.A1470","article-title":"Correlation of MR imaging findings and clinical manifestations in neurosarcoidosis","volume":"30","author":"R Shah","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref90","first-page":"305","volume-title":"Chapter 21 - Neurologic manifestations of sarcoidosis","author":"A Krumholz","year":"2014"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2013.09.008","article-title":"Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity","volume":"335","author":"O Wengert","year":"2013","journal-title":"J Neurol Sci"},{"issue":"11","key":"ref92","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00415-015-7853-x","article-title":"Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis","volume":"262","author":"S Tauhid","year":"2015","journal-title":"J Neurol"},{"issue":"01","key":"ref93","first-page":"25","article-title":"Neurosarcoidosis in a public safety net hospital: a study of 82 cases","volume":"36","author":"J Dorman","year":"2019","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"04","key":"ref94","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1212\/NXI.0000000000000722","article-title":"Clinical and MRI phenotypes of sarcoidosis-associated myelopathy","volume":"7","author":"O C Murphy","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"07","key":"ref95","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000002992","article-title":"Central canal enhancement and the trident sign in spinal cord sarcoidosis","volume":"87","author":"N L Zalewski","year":"2016","journal-title":"Neurology"},{"issue":"03","key":"ref96","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.24582","article-title":"Discriminating long myelitis of neuromyelitis optica from sarcoidosis","volume":"79","author":"E P Flanagan","year":"2016","journal-title":"Ann Neurol"},{"issue":"01","key":"ref97","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.crad.2015.09.007","article-title":"Imaging of neurosarcoidosis: common, uncommon, and rare","volume":"71","author":"G Bathla","year":"2016","journal-title":"Clin Radiol"},{"issue":"03","key":"ref98","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/WCO.0000000000000684","article-title":"Management of neurosarcoidosis: a clinical challenge","volume":"32","author":"M Voortman","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"24","key":"ref99","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1212\/WNL.0000000000003431","article-title":"Treatment of neurosarcoidosis: a comparative study of methotrexate and mycophenolate mofetil","volume":"87","author":"S Bitoun","year":"2016","journal-title":"Neurology"},{"issue":"02","key":"ref100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.rmed.2008.08.016","article-title":"Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis","volume":"103","author":"M Sodhi","year":"2009","journal-title":"Respir Med"},{"issue":"09","key":"ref101","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"V Deshpande","year":"2012","journal-title":"Mod Pathol"},{"issue":"08","key":"ref102","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/PAS.0b013e3181abdfc2","article-title":"IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease","volume":"33","author":"S-K Chan","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"06","key":"ref103","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamaneurol.2014.40","article-title":"Central nervous system manifestation of IgG4-related disease","volume":"71","author":"K Regev","year":"2014","journal-title":"JAMA Neurol"},{"issue":"12","key":"ref104","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/PAS.0b013e3181f7266b","article-title":"IgG4-related disease: a cross-sectional study of 114 cases","volume":"34","author":"Y Zen","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"06","key":"ref105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-015-0530-4","article-title":"IgG4-related ophthalmic disease: pooling of published cases and literature review","volume":"15","author":"A Wu","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"issue":"08","key":"ref106","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/bjophthalmol-2013-303131","article-title":"High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series","volume":"97","author":"R Deschamps","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"04","key":"ref107","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bjophthalmol-2012-302857","article-title":"Ocular adnexal IgG4-related disease: CT and MRI findings","volume":"97","author":"Y S Song","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"04","key":"ref108","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MD.0b013e31829cce35","article-title":"IgG4-related disease and hypertrophic pachymeningitis","volume":"92","author":"Z S Wallace","year":"2013","journal-title":"Medicine (Baltimore)"},{"issue":"04","key":"ref109","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.rdc.2017.06.010","article-title":"Neurologic features of immunoglobulin G4-related disease","volume":"43","author":"M AbdelRazek","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"issue":"02","key":"ref110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00296-019-04502-6","article-title":"Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review","volume":"40","author":"A G Vakrakou","year":"2020","journal-title":"Rheumatol Int"},{"issue":"09","key":"ref111","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1507\/endocrj.K09E-277","article-title":"Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity","volume":"56","author":"A Shimatsu","year":"2009","journal-title":"Endocr J"},{"issue":"02","key":"ref112","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-13-0642","article-title":"The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature","volume":"170","author":"H Bando","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"ref113","doi-asserted-by":"crossref","first-page":"e6205","DOI":"10.1097\/MD.0000000000006205","article-title":"Ophthalmic manifestations in IgG4-related disease: clinical presentation and response to treatment in a French case-series","volume":"96","author":"M Ebbo","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"06","key":"ref114","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"M N Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"09","key":"ref115","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of neuro-Beh\u00e7et's disease: international consensus recommendations","volume":"261","author":"S Kalra","year":"2014","journal-title":"J Neurol"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients","volume":"122","author":"G Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"ref117","first-page":"82","article-title":"The association between the parenchymal neurological involvement and posterior uveitis in Beh\u00e7et's syndrome","volume":"34","author":"B Bitik","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"05","key":"ref118","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1212\/NXI.0000000000000258","article-title":"Infliximab is a plausible alternative for neurologic complications of Beh\u00e7et disease","volume":"3","author":"B Zeydan","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"07","key":"ref119","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11910-018-0843-5","article-title":"Beh\u00e7et's syndrome and nervous system involvement","volume":"18","author":"U Uyguno\u011flu","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"01","key":"ref120","doi-asserted-by":"crossref","first-page":"10196","DOI":"10.1038\/s41598-017-09938-z","article-title":"Distinct clinical features between acute and chronic progressive parenchymal neuro-Beh\u00e7et disease: meta-analysis","volume":"7","author":"M Ishido","year":"2017","journal-title":"Sci Rep"},{"issue":"03","key":"ref121","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/s10165-011-0533-5","article-title":"Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis","volume":"22","author":"S Hirohata","year":"2012","journal-title":"Mod Rheumatol"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"51","DOI":"10.11604\/pamj.2015.20.51.5928","article-title":"Radiological findings in Beh\u00e7et disease","volume":"20","author":"C Mohamed","year":"2015","journal-title":"Pan Afr Med J"},{"issue":"04","key":"ref123","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.semarthrit.2014.08.004","article-title":"Tocilizumab for severe refractory neuro-Beh\u00e7et: three cases IL-6 blockade in neuro-Beh\u00e7et","volume":"44","author":"O Addimanda","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"05","key":"ref124","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00415-010-5885-9","article-title":"Cerebral venous thrombosis in Beh\u00e7et's disease: a systematic review","volume":"258","author":"D Aguiar de Sousa","year":"2011","journal-title":"J Neurol"},{"key":"ref125","first-page":"X18767053","article-title":"Cerebral venous thrombosis revealing Beh\u00e7et's disease in a Moroccan patient: a case report and literature review","volume":"6","author":"E Krumb","year":"2018","journal-title":"SAGE Open Med Case Rep"},{"issue":"01","key":"ref126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10067-017-3718-2","article-title":"Cerebral venous sinus thrombosis in Beh\u00e7et's disease: a retrospective case-control study","volume":"37","author":"J Shi","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"05","key":"ref127","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.autrev.2012.11.001","article-title":"Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Beh\u00e7et's disease: a systematic review and meta-analysis","volume":"12","author":"A-J Chamorro","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"03","key":"ref128","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neurol.2017.06.021","article-title":"Can anticoagulation therapy in cerebral venous thrombosis associated with Beh\u00e7et's disease be stopped without relapse?","volume":"174","author":"M Roriz","year":"2018","journal-title":"Rev Neurol (Paris)"},{"issue":"01","key":"ref129","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1186\/s40064-016-2721-4","article-title":"Headache in Behcet's disease: types and characteristics","volume":"5","author":"M Moghaddassi","year":"2016","journal-title":"Springerplus"},{"issue":"09","key":"ref130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11916-014-0445-0","article-title":"Headache in Beh\u00e7et's syndrome: review of literature and NYU Beh\u00e7et's syndrome center experience","volume":"18","author":"V Vishwanath","year":"2014","journal-title":"Curr Pain Headache Rep"},{"issue":"06","key":"ref131","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s11606-014-2781-5","article-title":"Neuro-Beh\u00e7et's disease: an unusual cause of headache","volume":"29","author":"E M Fountain","year":"2014","journal-title":"J Gen Intern Med"},{"issue":"02","key":"ref132","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/jnnp-2014-307614","article-title":"Stroke associated with giant cell arteritis: a population-based study","volume":"86","author":"M Samson","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"08","key":"ref133","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"G G Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"06","key":"ref134","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/modpathol.2017.10","article-title":"Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients","volume":"30","author":"J J Maleszewski","year":"2017","journal-title":"Mod Pathol"},{"key":"ref135","first-page":"S24","article-title":"Neurologic manifestations of giant cell arteritis","volume":"18","author":"G Nesher","year":"2000","journal-title":"Clin Exp Rheumatol"},{"issue":"S 02","key":"ref136","doi-asserted-by":"crossref","first-page":"ii22","DOI":"10.1093\/rheumatology\/kex461","article-title":"Ultrasound in the diagnosis and management of giant cell arteritis","volume":"57","author":"W A Schmidt","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"04","key":"ref137","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/WNO.0000000000000529","article-title":"Multiple cranial nerve palsies in giant cell arteritis","volume":"37","author":"M Ross","year":"2017","journal-title":"J Neuroophthalmol"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/EB.S170388","article-title":"Giant cell arteritis: early diagnosis is key","volume":"11","author":"I F Baig","year":"2019","journal-title":"Eye Brain"},{"issue":"04","key":"ref139","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"J H Stone","year":"2017","journal-title":"N Engl J Med"},{"issue":"03","key":"ref140","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/rheumatology\/keu336","article-title":"Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes","volume":"54","author":"G De Luna","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"01","key":"ref141","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/BOR.0b013e32834115f9","article-title":"Neurological involvement in Wegener's granulomatosis","volume":"23","author":"J U Holle","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"08","key":"ref142","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archneur.58.8.1215","article-title":"Standardized neurologic evaluations of 128 patients with Wegener granulomatosis","volume":"58","author":"K de Groot","year":"2001","journal-title":"Arch Neurol"},{"issue":"03","key":"ref143","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"J H Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3389\/fneur.2018.01166","article-title":"Central nervous system involvement in ANCA-associated vasculitis: what neurologists need to know","volume":"9","author":"Y Zheng","year":"2019","journal-title":"Front Neurol"},{"issue":"04","key":"ref145","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1468-1331.2009.02902.x","article-title":"Neurologic complications of Churg-Strauss syndrome--a prospective monocentric study","volume":"17","author":"J Wolf","year":"2010","journal-title":"Eur J Neurol"},{"issue":"22","key":"ref146","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.2169\/internalmedicine.8457-16","article-title":"Neurological complications in eosinophilic granulomatosis with polyangiitis (EGPA): the roles of history and physical examinations in the diagnosis of EGPA","volume":"56","author":"H Oiwa","year":"2017","journal-title":"Intern Med"},{"issue":"09","key":"ref147","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.autrev.2017.07.007","article-title":"Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): report of 26 patients and review of the literature","volume":"16","author":"R Andr\u00e9","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"02","key":"ref148","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ncl.2019.01.007","article-title":"Polyarteritis nodosa neurologic manifestations","volume":"37","author":"H de Boysson","year":"2019","journal-title":"Neurol Clin"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2014.01.029","article-title":"Diagnosis and classification of polyarteritis nodosa","volume":"48-49","author":"J Hern\u00e1ndez-Rodr\u00edguez","year":"2014","journal-title":"J Autoimmun"}],"container-title":["Seminars in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1733790.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T22:49:15Z","timestamp":1633646955000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1733790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":149,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2021,10,7]]},"published-print":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1733790","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0271-8235","1098-9021"],"issn-type":[{"type":"print","value":"0271-8235"},{"type":"electronic","value":"1098-9021"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}